This HTML5 document contains 39 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n7http://purl.org/net/nknouf/ns/bibtex#
n19http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n18http://linked.opendata.cz/resource/domain/vavai/subjekt/
n9http://linked.opendata.cz/ontology/domain/vavai/
n10https://schema.org/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n12http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00064165%3A_____%2F11%3A9159%21RIV12-MZ0-00064165/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n4http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n20http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n5http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n14http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n13http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n16http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00064165%3A_____%2F11%3A9159%21RIV12-MZ0-00064165
rdf:type
n9:Vysledek skos:Concept
rdfs:seeAlso
http://www.intechopen.com/articles/show/title/incretin-based-treatment-strategy-glp-1-receptor-agonists-glp-1r-or-so-called-incretin-mimetics
dcterms:description
The pharmacotherapy of Type 2 Diabetes Mellitus (T2DM) has, in the past 60 years, been developing in unison with the advances in our understanding of diabetes athophysiology. As our knowledge developed and changed, so did appear new drugs which better and inmore targeted fashion rectified the pathological processes leading to the development of diabetes. The pharmacotherapy of Type 2 Diabetes Mellitus (T2DM) has, in the past 60 years, been developing in unison with the advances in our understanding of diabetes athophysiology. As our knowledge developed and changed, so did appear new drugs which better and inmore targeted fashion rectified the pathological processes leading to the development of diabetes.
dcterms:title
Incretin-Based Treatment Strategy - GLP-1 Receptor Agonists (GLP-1R) or So-Called Incretin Mimetics Incretin-Based Treatment Strategy - GLP-1 Receptor Agonists (GLP-1R) or So-Called Incretin Mimetics
skos:prefLabel
Incretin-Based Treatment Strategy - GLP-1 Receptor Agonists (GLP-1R) or So-Called Incretin Mimetics Incretin-Based Treatment Strategy - GLP-1 Receptor Agonists (GLP-1R) or So-Called Incretin Mimetics
skos:notation
RIV/00064165:_____/11:9159!RIV12-MZ0-00064165
n9:predkladatel
n18:ico%3A00064165
n3:aktivita
n5:V
n3:aktivity
V
n3:dodaniDat
n16:2012
n3:domaciTvurceVysledku
n19:2051931
n3:druhVysledku
n14:C
n3:duvernostUdaju
n20:S
n3:entitaPredkladatele
n12:predkladatel
n3:idSjednocenehoVysledku
204130
n3:idVysledku
RIV/00064165:_____/11:9159
n3:jazykVysledku
n11:eng
n3:klicovaSlova
Diabetes mellitus type 2; pharmacotherapy; past 60 years; treatment methods
n3:klicoveSlovo
n4:pharmacotherapy n4:Diabetes%20mellitus%20type%202 n4:past%2060%20years n4:treatment%20methods
n3:kontrolniKodProRIV
[1BCE39E45F7D]
n3:mistoVydani
Rijeka
n3:nazevZdroje
Topics in the Prevention, Treatment and Complications of Type 2 Diabetes
n3:obor
n13:FB
n3:pocetDomacichTvurcuVysledku
1
n3:pocetStranKnihy
340
n3:pocetTvurcuVysledku
2
n3:rokUplatneniVysledku
n16:2011
n3:tvurceVysledku
Perušičová, Jindřiška Owen, Klára
s:numberOfPages
26
n7:hasPublisher
Hard cover
n10:isbn
978-953-307-590-7